Original Research
Accepted on 12 Feb 2026
Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
Type at least 3 characters
656 articles
articles
Review
Published on 10 Feb 2026
Cellular strategies for repairing trapped protein-DNA complexes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1716415
- 305 views
Mini Review
Published on 09 Feb 2026
Pharmacogenomics of risperidone in autism spectrum disorder: a minireview
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1768109
- 428 views
Original Research
Published on 06 Feb 2026
CYP2C19 genotype-guided escalation to ticagrelor vs. clopidogrel in secondary stroke prevention: a retrospective cohort study
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1747121
- 462 views
Original Research
Accepted on 03 Feb 2026
Sertraline safety in adolescents experiencing a depressive episode during first 3 weeks: added anxiolytic matters more than CYP2C19 polymorphisms
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
- 125 views
Original Research
Published on 03 Feb 2026
Pharmacogenomic and in silico identification of isoform-selective AKT inhibitors from Pithecellobium dulce for precision cancer therapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1744408
- 527 views
Case Report
Published on 30 Jan 2026
Case Report: Severe SIADH and QTc prolongation induced by escitalopram-quetiapine interaction in a CYP2C19 intermediate metabolizer at therapeutic doses
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1776959
- 624 views
Original Research
Accepted on 29 Jan 2026
LITAF suppresses breast cancer and paclitaxel resistance by ubiquitinating and degrading PCMT1 to inhibit COX-2-dependent arachidonic acid metabolism
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
- 130 views
Editorial
Accepted on 29 Jan 2026
Editorial: Innovations in PGx: embracing diversity and clinical application
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
- 134 views
Perspective
Accepted on 29 Jan 2026
Pharmacogenomics and Genetic Ancestry: An Opportunity to Transform Clinical Practice in Colombia
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
- 249 views
Original Research
Published on 28 Jan 2026
NAPQI adducts in patients with selective hypersensitivity to acetaminophen
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1726508
- 937 views
Review
Published on 22 Jan 2026
Addressing genetic diversity and health inequities: RELIVAF’s proposal for Latin American pharmacogenomic guidelines
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1721828
- 906 views
Original Research
Published on 21 Jan 2026
Transcriptional response to combination antiretroviral therapy predicts side effects and novel targets
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1743543
- 588 views
Original Research
Published on 21 Jan 2026
The post-marketing safety of venlafaxine: a real-world two-decade pharmacovigilance study using the FAERS database
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1737113
- 786 views
Original Research
Accepted on 19 Jan 2026
DPYD Genotyping in Patients Receiving Capecitabine: An exploratory analysis from the D-TORCH study
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
- 291 views
Original Research
Published on 16 Jan 2026
Near, far, wherever you are: phenotype-related variation in pharmacogenomic effect sizes across the psychiatric drug literature
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1719761
- 654 views
Review
Published on 12 Jan 2026
Combining exercise and nanoparticle-based therapies: a review of physiological synergies and pharmacological potential
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1679552
- 942 views
Mini Review
Published on 08 Jan 2026
ITGA4 genetic variants as a predictor of therapeutic responsivity to autoimmune diseases
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1745315
- 829 views
Mini Review
Published on 19 Dec 2025
Transcriptional rewiring in cancer driven by POLR2A/RPB1: mechanistic insights, non-coding RNA crosstalk, and therapeutic opportunities
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1745087
- 1,464 views
Methods
Published on 02 Dec 2025
StarTRAC-CYP2D6: a method for CYP2D6 allele-specific copy number determination using digital PCR
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1715830
- 1,564 views
Original Research
Published on 27 Nov 2025
Effectiveness of treatments to prevent femoral periprosthetic bone loss following total hip arthroplasty: a network meta-analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1566890
- 1,432 views
- 1 citation
Original Research
Published on 25 Nov 2025
Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1697866
- 1,632 views
Original Research
Published on 21 Nov 2025
Assessing the views and opinions of psychiatric patients receiving genome-guided treatment within the scope of the PREPARE preemptive pharmacogenomics clinical study
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1722339
- 1,060 views
Systematic Review
Published on 21 Nov 2025
Impact of CYP2C19 point-of-care testing on the clinical outcome in patients receiving personalized clopidogrel therapy: systemic review and meta-analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1621327
- 1,685 views